Search results: Found 102

Listing 1 - 10 of 102 << page
of 11
>>
Sort by
Good Research Practice in Non-Clinical Pharmacology and Biomedicine

Authors: --- ---
Book Series: Handbook of Experimental Pharmacology ISBN: 9783030336561 Year: Pages: 423 DOI: 10.1007/978-3-030-33656-1 Language: English
Publisher: Springer Nature
Subject: Medicine (General) --- Neurology
Added to DOAB on : 2020-06-16 23:59:54
License:

Loading...
Export citation

Choose an application

Abstract

This open access book, published under a CC BY 4.0 license in the Pubmed indexed book series Handbook of Experimental Pharmacology, provides up-to-date information on best practice to improve experimental design and quality of research in non-clinical pharmacology and biomedicine.

High Density Lipoproteins: From Biological Understanding to Clinical Exploitation

Authors: ---
Book Series: Handbook of Experimental Pharmacology ISSN: 01712004 ISBN: 9783319096643 9783319096650 Year: Volume: 224 Pages: 694 DOI: 10.1007/978-3-319-09665-0 Language: English
Publisher: Springer Nature
Subject: Manufactures --- Electrical and Nuclear Engineering --- Chemical Technology --- Business and Management --- Biotechnology --- Therapeutics --- Medicine (General)
Added to DOAB on : 2015-07-20 15:18:00
License:

Loading...
Export citation

Choose an application

Abstract

n this Handbook of Experimental Pharmacology on “High Density Lipoproteins – from biological understanding to clinical exploitation” contributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation.The book is of interest to researchers in academia and industry focusing on lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases.

The Emerging Discipline of Quantitative Systems Pharmacology

Authors: ---
Book Series: Frontiers Research Topics ISSN: 16648714 ISBN: 9782889196425 Year: Pages: 97 DOI: 10.3389/978-2-88919-642-5 Language: English
Publisher: Frontiers Media SA
Subject: Science (General) --- Therapeutics
Added to DOAB on : 2016-08-16 10:34:25
License:

Loading...
Export citation

Choose an application

Abstract

In 2011, the National Institutes of Health (NIH), in collaboration with leaders from the pharmaceutical industry and the academic community, published a white paper describing the emerging discipline of Quantitative Systems Pharmacology (QSP), and recommended the establishment of NIH-supported interdisciplinary research and training programs for QSP. QSP is still in its infancy, but has tremendous potential to change the way we approach biomedical research. QSP is really the integration of two disciplines that have been increasingly useful in biomedical research; “Systems Biology” and “Quantitative Pharmacology”. Systems Biology is the field of biomedical research that seeks to understand the relationships between genes and biologically active molecules to develop qualitative models of these systems; and Quantitative Pharmacology is the field of biomedical research that seeks to use computer aided modeling and simulation to increase our understanding of the pharmacokinetics (PK) and pharmacodynamics (PD) of drugs, and to aid in the design of pre-clinical and clinical experiments. The purpose of QSP modeling is to develop quantitative computer models of biological systems and disease processes, and the effects of drug PK and PD on those systems. QSP models allow testing of numerous potential experiments “in-silico” to eliminate those associated with a low probability of success, avoiding the potential costs of evaluating all of those failed experiments in the real world. At the same time, QSP models allow us to develop our understanding of the interaction between drugs and biological systems in a more systematic and rigorous manner. As the need to be more cost-efficient in the use of research funding increases, biomedical researchers will be required to gain the maximum insight from each experiment that is conducted. This need is even more acute in the pharmaceutical industry, where there is tremendous competition to develop innovative therapies in a highly regulated environment, combined with very high research and development (R&D) costs for bringing new drugs to market (~$1.3 billion/drug). Analogous modeling & simulation approaches have been successfully integrated into other disciplines to improve the fundamental understanding of the science and to improve the efficiency of R&D (e.g., physics, engineering, economics, etc.). The biomedical research community has been slow to integrate computer aided modeling & simulation for many reasons: including the perception that biology and pharmacology are “too complex” and “too variable” to be modeled with mathematical equations; a lack of adequate graduate training programs; and the lack of support from government agencies that fund biomedical research. However, there is an active community of researchers in the pharmaceutical industry, the academic community, and government agencies that develop QSP and quantitative systems biology models and apply them both to better characterize and predict drug pharmacology and disease processes; as well as to improve efficiency and productivity in pharmaceutical R&D.

The Physiology and Pharmacology of Leucine-rich Repeat GPCRs

Authors: ---
Book Series: Frontiers Research Topics ISSN: 16648714 ISBN: 9782889199587 Year: Pages: 115 DOI: 10.3389/978-2-88919-958-7 Language: English
Publisher: Frontiers Media SA
Subject: Medicine (General) --- Internal medicine
Added to DOAB on : 2016-01-19 14:05:46
License:

Loading...
Export citation

Choose an application

Abstract

G protein-coupled receptors (GPCRs) represent a large and physiologically important class of cell surface receptors. There are approximately 750 known GPCRs present in the human genome that can be subdivided into general classes based upon sequence homology within their transmembrane domains. Therapeutically, GPCRs represent a fertile source for the development of therapies as they are a significant percentage of our current pharmacopeia. Among the three subclasses of GPCRs, the Class A (rhodopsin-like) receptors are by far the most prevalent and extensively studied. However, within the Class A receptors, sub-families of receptors can be distinguished based upon common sequence motifs within the transmembrane domains as well as extracellular and intracellular domains. One such family of Class A receptors is characterized by multiple leucine- rich repeats within their amino- terminal domains (the Leucine-rich Repeat family (LRR)). This family of GPCRs are best represented by the glycoprotein hormone receptors (LHR, FSHR and TSHR) which have been studied extensively but also includes receptors for the peptide hormone relaxin (RXFP1 and RXFP2 (RXFP2 also binds insulin-like peptide 3)) and three other receptors (LGR4, LGR5 and LGR6). LGR4-6 were, until recently, considered orphan receptors. However, emerging data have revealed that these proteins are the receptors for a family of growth factors called R-spondins. Over the last 20 years much has been learned about LRR receptors, including the development of synthetic agonists and antagonists, new insights into signaling (including signaling bias) and the physiological role these receptors play in regulating the function of many tissues. This topic will focus on what is known concerning the regulation of these receptors, their signaling pathways, functional consequences of activation and pharmacology.

Keywords

GPCR --- Leucine- rich repeat --- LH --- FSH --- TSH --- Relaxin --- R-spondin --- LRR --- Pharmacology

Molecular Pharmacology and Pathology of Strokes

Authors: ---
ISBN: 9783038975410 9783038975427 Year: Pages: 152 DOI: 10.3390/books978-3-03897-542-7 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Medicine (General) --- Therapeutics --- Cardiovascular
Added to DOAB on : 2019-02-11 11:33:53
License:

Loading...
Export citation

Choose an application

Abstract

Stroke, a progressively non-communicable disease, is the second leading cause of death after coronary heart disease in developed countries. The present treatment options for stroke are adapting lifestyle practices, diabetes treatment, drugs, and the management of other factors, but no cure is yet available, despite new insights into molecular and therapeutic targets. Discoveries related to explicating the molecular pharmacology in cerebrovascular function and thrombosis have led to significant advancements in the current treatment paradigm for patients with stroke. Hence, this Special Issue invited scientific papers and reviews from researchers to provide solid evidence from a molecular point of view to scrutinize the molecular pharmacology and pathology of strokes. Platelet activation plays a major role in cardio and cerebrovascular diseases. Platelets also play a key role in the hemostatic process and are associated with various pathological events, such as arterial thrombosis and atherosclerosis. While the currently used anti-platelet drugs such as aspirin and clopidogrel demonstrate efficacy in many patients, they exert undesirable side effects. Therefore, the development of effective therapeutic strategies for the prevention and treatment of thrombotic diseases is a significant priority. Recently, precious metal drugs have conquered the subject of metal-based drugs, and several investigators have moved their attention to the synthesis of various ruthenium (Ru) and iridium (Ir) complexes due to their prospective therapeutic values. We have published this e-book about the “Molecular Pharmacology and Pathology of Strokes” and anticipate that readers will find this book useful regarding the significant challenges and current advances that are presently being made in stroke research, with the possibility of inspiring the application of novel drug development to enrich the devotion and treatment of patients with cardiovascular diseases.

Biological Activities of Alkaloids: From Toxicology to Pharmacology

Authors: --- --- ---
ISBN: 9783039289271 / 9783039289288 Year: Pages: 270 DOI: 10.3390/books978-3-03928-928-8 Language: eng
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Medicine (General) --- Therapeutics
Added to DOAB on : 2020-06-09 16:38:57
License:

Loading...
Export citation

Choose an application

Abstract

Natural products are increasingly attracting attention from both basic and applied science. Plant secondary metabolites, especially alkaloids, are receiving interest from a wide range of researchers due to their biological activity. They are produced to protect plants from diseases and herbivores. Therefore, they reveal a toxic activity that affects organisms at various levels of biological organization. A growing amount of research is proving their antimicrobial, antifungal, insecticidal, and anticancer activities. That makes them applicable in various fields from medicine, to pharmacology, veterinary, and toxicology, to crop protection. This Special Issue of Toxins, “Biological Activities of Alkaloids: From Toxicology to Pharmacology"", collects 15 manuscripts describing the ecological, biological, pharmacological, and toxicological effects as well as structural and analytical aspects of plant alkaloids, their mode of action, and possible application in veterinary, medicine, and plant protection. These studies prove the potential for alkaloid application in various areas of science.

Keywords

Arecoline --- lung cancer cells --- mAchR3 --- EGFR --- SRC --- FAK --- dehydrocrenatidine --- neuropathic pain --- voltage-gated sodium channels --- Solanum melongena L. --- malonylated form --- glycoalkaloids --- secondary metabolites --- solasonine --- solamargine --- malonyl-solamargine --- acetylcholinesterase --- antioxidant --- Ovarian cancer --- Rutidea parviflora --- Palmatine --- Apoptosis --- chanoclavine --- toxicology --- subchronic feeding study --- acute toxicity --- endophyte --- Epichloë --- plant secondary metabolites --- glycoalkaloids --- insect heart --- beetles --- insect --- Tenebrio molitor --- Radix Aconiti Lateralis preparations --- short-term and long-term usage --- di-ester diterpenoid alkaloids --- mono-ester diterpenoid alkaloids --- biodistribution --- ergot alkaloids --- livestock --- reproduction --- isoquinoline alkaloids --- antimicrobial activity --- Chelidonium majus --- cytotoxicity --- apoptosis --- sanguinarine --- berberine --- Chelidonium majus --- Berberis thunbergii --- leukemia --- anticancer --- natural products --- alkaloids --- plant secondary metabolites --- ?-carboline --- Staphylococcus aureus --- antimicrobial activity --- cytotoxicity --- acid-sensing ion channel subtype 1a --- bisbenzylisoquinoline alkaloid --- lindoldhamine --- nociception --- inflammation --- isoquinoline alkaloids --- HPLC-DAD --- cytotoxic activity --- Mahonia aquifolia --- Meconopsis cambrica --- Corydalis lutea --- Dicentra spectabilis --- Fumaria officinalis --- Macleaya cordata --- alkaloids --- natural sources --- anticancer --- antibacterial --- antiviral --- antifungal --- Curine --- alkaloid --- macrophage --- neutrophil --- lipopolysaccharide --- n/a

Computational and Experimental Approaches in Multi-Target Pharmacology

Author:
Book Series: Frontiers Research Topics ISSN: 16648714 ISBN: 9782889452521 Year: Pages: 122 DOI: 10.3389/978-2-88945-252-1 Language: English
Publisher: Frontiers Media SA
Subject: Science (General) --- Therapeutics
Added to DOAB on : 2018-02-27 16:16:44
License:

Loading...
Export citation

Choose an application

Abstract

The next frontier in pharmacology is the development of multi-target strategies in which pathological processes are controlled by pharmacologically manipulating them at many different points at once. Designing multi-target strategies will require deep understanding of the complex physiology that underlies pathological processes. It will also require the development of single drugs with multiple targets, or combinations of drugs with compatible pharmacokinetics that work synergistically to maximize desirable effects while minimizing unwanted side effects. This e-Book contains ten original articles, each addressing a different aspect of this challenge. Together they open new perspectives and show the way forward in the development of multi-target therapeutics.

Simon of Genoa's Medical Lexicon

Author:
ISBN: 9788376560236 Year: Pages: 164 DOI: 10.2478/9788376560236 Language: English
Publisher: De Gruyter
Subject: History
Added to DOAB on : 2014-03-05 13:12:22
License:

Loading...
Export citation

Choose an application

Abstract

“Simon of Genoa's Medical Lexicon”, an edited volume based on the conference held on March 17th, 2012, is part of the Simon Online project – a dynamically growing Wiki edition of Simon of Genoa's Clavis sanationis, a Latin-Greek-Arabic medical dictionary from the late 13th century. In the individual articles, written by well-known scholars, authorities in their fields of research, Simon and his major work, are approached from different perspectives and as a whole. The volume offers a comprehensible and well-balanced collection of current research on Simon and Clavis sanationis.The volume demonstrates the importance of the Clavis, not only for the history of pharmacology and medicine, but also for Byzantine and medieval studies, Roman, Greek, Latin and Arabic philology and lexicography.Barbara Zipser (Doctor of Philosophy, Wellcome Trust University Award 2006, 2010) is a researcher at the Centre for the Study of the Body and Material Culture, History Department, Royal Holloway University of London. Her main field of research is Greek medicine from Galen to the late Middle Ages, with an emphasis on textual criticism, manuscript transmission, and the formation of Greek vernacular terminology. Dr Zipser is a well-known and promising young scholar in the field of Ancient and Medieval Medicine. She runs Simon Online (http://www.simonofgenoa.org) – the joint edition and translation project of Simon of Genoa's Clavis sanationis, a dictionary of Latin, Greek and Arabic medical terminology in Wiki format.

Alternatives to Animal Testing

Authors: --- ---
ISBN: 9789811324475 Year: Pages: 130 DOI: 10.1007/978-981-13-2447-5 Language: English
Publisher: Springer Nature
Subject: Medicine (General) --- Biology
Added to DOAB on : 2020-02-04 11:21:24
License:

Loading...
Export citation

Choose an application

Abstract

This open access book presents recent advances in the pure sciences that are of significance in the quest for alternatives to the use of animals in research and describes a variety of practical applications of the three key guiding principles for the more ethical use of animals in experiments – replacement, reduction, and refinement, collectively known as the 3Rs. Important examples from across the world of implementation of the 3Rs in the testing of cosmetics, chemicals, pesticides, and biologics, including vaccines, are described, with additional information on relevant regulations. The coverage also encompasses emerging approaches to alternative tests and the 3Rs. The book is based on the most informative contributions delivered at the Asian Congress 2016 on Alternatives and Animal Use in the Life Sciences. It will be of value for those working in R&D, for graduate students, and for educators in various fields, including the pharmaceutical and cosmetic sciences, pharmacology, toxicology, and animal welfare. The free, open access distribution of Alternatives to Animal Testing is enabled by the Creative Commons Attribution license in International version 4: CC BY 4.0.

Resveratrol - Adding Life to Years, Not Adding Years to Life

Author:
ISBN: 9781789849943 9781789849950 Year: Pages: 166 DOI: 10.5772/intechopen.74428 Language: English
Publisher: IntechOpen
Subject: Pharmacy and materia medica
Added to DOAB on : 2019-10-03 07:51:52

Loading...
Export citation

Choose an application

Abstract

This book intends to strike a balance between developments in research and the fact that researchers must absorb and link to scientific advances with clinical practice so that the management of diseases can be based on sound physiological concepts. This book addresses several controversial issues regarding a natural molecule with fascinating pharmacological and therapeutic effects. The book contains three sections: Section 1: Pharmacology and Therapeutic Applications of Resveratrol; Section 2: Bioavailability, Metabolism, and Mode of Action of Resveratrol; Section 3: Resveratrol and Its Role in Chronic and Degenerative Diseases. Does it Add Life to Years or Years to Life? It is our hope that this book will motivate readers to approach the evidence on the use resveratrol and thereby spark an interest in making further contributions to the current scientific debate and treatment development efforts.

Listing 1 - 10 of 102 << page
of 11
>>
Sort by